{
  "id": 18272223,
  "title": "Alethio clinches $90M to advance antibody for essential thrombocythemia",
  "url": "https://urgent.news/2026/11/05/alethio-clinches-90m-to-advance-antibody-for-essential-thrombocythemia",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-05T08:00:50.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/alethio-clinches-90m-to-advance-antibody-for-essential-thrombocythemia/"
  },
  "original_language": "en",
  "account": null,
  "summary": "About a year after emerging from stealth, University of Oxford spinout Alethio Therapeutics has collected $90 million in a Series A raise to support its lead rare blood cancer program through ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}